as 02-13-2025 10:44am EST
GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. GeneDx is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.
Upcoming Earnings Alert:
Get ready for potential market movements as GeneDx Holdings Corp. WGS prepares to release earnings report on 18 Feb 2025.
Founded: | 2017 | Country: | United States |
Employees: | N/A | City: | STAMFORD |
Market Cap: | 2.0B | IPO Year: | N/A |
Target Price: | $80.60 | AVG Volume (30 days): | 1.0M |
Analyst Decision: | Strong Buy | Number of Analysts: | 5 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -3.16 | EPS Growth: | N/A |
52 Week Low/High: | $3.90 - $98.87 | Next Earning Date: | 02-18-2025 |
Revenue: | $267,228,000 | Revenue Growth: | 29.41% |
Revenue Growth (this year): | 44.7% | Revenue Growth (next year): | 16.73% |
WGS Breaking Stock News: Dive into WGS Ticker-Specific Updates for Smart Investing
Business Wire
2 hours ago
Business Wire
19 hours ago
Associated Press Finance
3 days ago
Business Wire
3 days ago
MT Newswires
8 days ago
Business Wire
16 days ago
Simply Wall St.
24 days ago
Business Wire
a month ago
The information presented on this page, "WGS GeneDx Holdings Corp. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.